DuPont de Nemours, Inc.
NYSE:DDChemicals - Specialty
-$0.26 today
- Market cap
- $19.91B
- Beta
- 1.08
- P/E (TTM)
- -674.4
- EPS (TTM)
- -$0.07
- Dividend yield
- 1.62%
Volume 1.33M
Average 3.65M
DD Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
DuPont de Nemours, Inc.NYSE: DD
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue declines year over year
Q2 FY2026 cost of revenue of $1.18B fell 45.9% year over year, behind the -34.1% change in trailing-twelve-month cost of revenue. Sequentially, it rose 9.4% from the prior quarter. Over 3 fiscal years it compounded at -19.0% a year.
Context
- Cost of revenue amounted to 69.7% of revenue in FY2025, up 1.3 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -45.9% toward the trailing-twelve-month pace of -34.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 4.78B USD
- Year-over-year change
- -43.6%
- 4-year CAGR
- -13.5%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.78B | -43.6% |
| FY2024 | 2024-12-31 | 8.47B | +0.5% |
| FY2023 | 2023-12-31 | 8.44B | -6.2% |
| FY2022 | 2022-12-31 | 8.99B | +5.3% |
| FY2021 | 2021-12-31 | 8.54B | — |
Cost of Revenue vs competitors
How DD compares with its peers on the latest reported figures
- DD's LTM Jun 2026 cost of revenue of $5.42B is the 6th highest of the 9 companies compared; the peer median is $7.43B.
- Its year-over-year change of -34.1% is the lowest of 9, against a peer median of +1.4%.
- Cost of revenue amounts to 65.6% of revenue for DD, versus a peer median of 79.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $37.88B | -0.6% | -8.5% | 88.9% | |
| LTM Sep 2026 | $27.27B | -7.7% | -14.5% | 85.3% | |
| LTM Sep 2026 | $15.27B | +3.6% | -7.8% | 60.5% | |
| LTM Jun 2026 | $7.75B | -0.3% | +2.1% | 79.8% | |
| LTM Jun 2026 | $7.1B | +0.7% | -6.6% | 80.1% | |
| LTM Jun 2026 | $5.42B | -34.1% | -19.0% | 65.6% | |
| LTM Jun 2026 | $4.91B | +2.1% | -2.0% | 84.7% | |
| LTM Sep 2026 | $2.32B | +5.3% | -4.3% | 67.9% | |
| LTM Sep 2026 | $2.21B | +52.7% | -2.5% | 63.4% | |
| Peer median (excluding DD) | $7.43B | +1.4% | -5.5% | 79.9% | |
Competitors are the stored peer set for DD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.57B | 13.02B | 12.07B | 12.39B | 6.85B |
| Cost of Revenue | 8.54B | 8.99B | 8.44B | 8.47B | 4.78B |
| Gross Profit | 4.03B | 4.03B | 3.63B | 3.91B | 2.07B |
| Gross Margin | 32.1% | 30.9% | 30.1% | 31.6% | 30.3% |
| Research & Development | 557M | 536M | 508M | 531M | 193M |
| Selling, General & Admin | 1.6B | 1.47B | 1.41B | 1.55B | 1.02B |
| Operating Expenses | 2.16B | 2B | 1.92B | 2.08B | 1.21B |
| Depreciation & Amortization | 1.11B | 1.14B | 1.15B | 1.19B | 647M |
| EBITDA | 3.08B | 3.08B | 2.05B | 2.75B | 1.16B |
| EBITDA Margin | 24.5% | 23.6% | 17.0% | 22.2% | 16.9% |
| Operating Income | 1.87B | 2.02B | 1.72B | 1.83B | 860M |
| Operating Margin | 14.9% | 15.5% | 14.2% | 14.8% | 12.6% |
| Interest Income | 12M | 50M | 155M | 73M | 98M |
| Interest Expense | 525M | 492M | 396M | 366M | 313M |
| Other Income / Expenses | (426M) | (574M) | (1.21B) | (637M) | (660M) |
| Income Before Tax | 1.44B | 1.45B | 504M | 1.19B | 200M |
| Pre-Tax Margin | 11.5% | 11.1% | 4.2% | 9.6% | 2.9% |
| Income Tax Expense | 237M | 387M | (29M) | 414M | 102M |
| Net Income | 6.47B | 5.87B | 423M | 703M | (779M) |
| Net Margin | 51.5% | 45.1% | 3.5% | 5.7% | -11.4% |
| EPS (Basic) | 35.76 | 34.89 | 2.82 | 5.04 | (5.61) |
| EPS (Diluted) | 35.64 | 34.83 | 2.82 | 5.04 | (5.58) |
| Weighted Avg Shares | 180.9M | 166.17M | 149.97M | 139.73M | 139.17M |
| Weighted Avg Shares (Diluted) | 181.4M | 166.47M | 150.4M | 140.2M | 139.73M |
DuPont de Nemours, Inc.
NYSE:DD
Intrinsic Alpha fair value
Locked
Current Price
$150.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.